Privia Health (PRVA) Shares Outstanding (Weighted Average) (2020 - 2025)
Privia Health has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $122.2 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $122.2 million for Q4 2025, up 2.32% from a year ago — trailing twelve months through Dec 2025 was $122.2 million (up 2.32% YoY), and the annual figure for FY2025 was $122.2 million, up 2.32%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $122.2 million at Privia Health, roughly flat from $122.8 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for PRVA hit a ceiling of $122.8 million in Q3 2025 and a floor of $96.0 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $116.2 million (2023), compared with a mean of $113.7 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.06% in 2021 and later grew 12.58% in 2022.
- Privia Health's Shares Outstanding (Weighted Average) stood at $103.0 million in 2021, then rose by 7.52% to $110.7 million in 2022, then grew by 5.45% to $116.7 million in 2023, then increased by 2.29% to $119.4 million in 2024, then grew by 2.32% to $122.2 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $122.2 million (Q4 2025), $122.8 million (Q3 2025), and $122.1 million (Q2 2025) per Business Quant data.